In relation to the adverse effects of CRP (Table 3), 5.2% of participants in the multiple CRP group developed CS compared to 3.8% in the single CRP group; however, the difference was not statistically significant (P = 0.602). The gene discussed is CRP; the disease is Cowden syndrome 1.